A 46- year-old woman with rigidity and frequent falls

Cleveland Clinic Journal of Medicine

Volumn 72, Issue 1, 2005, Pages 57-63

  Tousi, Babak ^a   Schuele, Stephan U ^a   Subramanian, Thyagarajan ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; APOMORPHINE; BROMOCRIPTINE; CALCIUM; CARBIDOPA PLUS LEVODOPA; CERULOPLASMIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; COPPER; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; EPHEDRINE; ERYTHROPOIETIN; FLUDROCORTISONE; INDOMETACIN; LEVODOPA; MIDODRINE; OCTREOTIDE; OXYBUTYNIN; PHOSPHORUS; PRAMIPEXOLE; ROPINIROLE; SELEGILINE; SILDENAFIL; THREO 3,4 DIHYDROXYPHENYLSERINE; TOLCAPONE;

AUTONOMIC DYSFUNCTION; CERULOPLASMIN BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CONSTIPATION; COPPER BLOOD LEVEL; DAILY LIFE ACTIVITY; DISEASE EXACERBATION; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG DOSE REGIMEN; DRUG FATALITY; DYSKINESIA; ERECTILE DYSFUNCTION; FALLING; FLUID INTAKE; FUNCTIONAL DISEASE; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERKINESIA; HYPOKINESIA; HYPOTHYROIDISM; LIVER TOXICITY; MALAISE; MOTOR DYSFUNCTION; MYALGIA; NAUSEA AND VOMITING; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PARKINSONISM; POSITIVE END EXPIRATORY PRESSURE; PROGNOSIS; PROGRESSIVE SUPRANUCLEAR PALSY; RESPIRATORY TRACT DISEASE; REVIEW; RIGIDITY; SALT INTAKE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SKIN TINGLING; SUSTAINED RELEASE FORMULATION; TRACHEOSTOMY; TREATMENT FAILURE; TREMOR; URINALYSIS; URINE INCONTINENCE;

EID: 12744260163     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.72.1.57     Document Type: Review

References (29)

1. Jankovic J. The extrapyramidal disorders, In: Bennett JC, Plum F. Cecil Textbook of Medicine. 20th ed. Philadelphia, PA: WB Saunders Co; 1996:2042-2046.
2. Waters CH. Diagnosis and management of Parkinson's disease. 2nd ed. Caddo, OK: Professional Communications Inc.; 1999:11-16.
3. Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990. Neurology 1999; 52:1214-1220.
4. Lang AE, Lozano, AM. Parkinson's disease. First of two parts. N Engl J Med 1998; 339:1044-1053.
5. Lang AE, Lozano AM. Parkinson's disease. Second of two parts. N Engl J Med 1998; 339:1130-1143.
6. Gelb DJ, Oliver E, Gilman, S. Diagnostic criteria of Parkinson disease. Arch Neurol 1999; 56:33-39.
7. Wenning GK, Ben-Shlomo Y, Hughes A, Daniel SE, Lees A, Quinn NP. What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease? J Neurol Neurosurg Psychiatry 2000; 68:434-440.
8. Wenning GK, Ben Shlomo Y, Magalhaes M, Daniel SE, Quinn NP. Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain 1994; 117:835-845.
9. Gilman S, Low PA, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999; 163:94-98.
10. Ghaemi M, Hilker R, Rudolf J, Sobesky J, Heiss WD. Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging. J Neurol Neurosurg Psychiatry 2002; 73:517-23.
11. Wenning GK, Ebersbach G, Verny M, et al. Progression of falls in postmortem-confirmed parkinsonian disorders. Mov Disord 1999; 14:947-950.
12. Litvan I, Mangone CA, McKee A, et al. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry 1996; 60:615-620.
13. Wenning GK, Litvan I, Jankovic J, et al. Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry 1998; 64:184-189.
14. Golbe LI, Davis PH, Schoenberg BS, Duvoisin RC. Prevalence and natural history of progressive supranuclear palsy. Neurology 1988; 38:1031-1034.
15. Hughes AJ, Daniel SE, Blankson S, Lees AJ. A clinicopathological study of 100 cases of Parkinson's disease. Arch Neurol 1993; 50:140-148.
16. Schrag A, Good CD, Miszkiel K, et al. Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology 2000; 54:697-702.
17. Tolosa E, Marti MJ, Valldeoriola F, Molinuevo JL. History of levodopa and dopamine agonists in Parkinson's disease treatment. Neurology 1998; 50:S2-S10; discussion S44-S48.
18. Miyasaki JM, Martin W, Suchowersky O, Weiner WJ, Lang AE. Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2002; 58:11-17.
19. Hughes AJ, Colosimo C, Kleedorfer B, Daniel SE, Lees AJ. The dopaminergic response in multiple system atrophy. J Neurol Neurosurg Psychiatry 1992; 55:1009-1013.
20. Waters C, Constantino A. The use of COMT inhibitors in older patients. Geriatric Times 2001. www.geriatrictimes.com/g010324.html.
21. Goetz CG, Tanner CM, Klawans HL. The pharmacology of olivopontocerebellar atrophy. Adv Neurol 1984; 41:13-148.
22. Beck RO, Betts CD, Fowler CJ. Genitourinary dysfunction in multiple system atrophy: clinical features and treatment in 62 cases. J Urol 1994; 151:1336-1341.
23. Rossi P, Colosimo C, Moro E, Tonali P, Albanese A. Acute challenge with apomorphine and levodopa in Parkinsonism. Eur Neurol 2000; 43:95-101.
24. Botez MI, Botez-Marquard T, Elie R, Le Marec N, Pedraza OL, Lalonde R. Amantadine hydrochloride treatment in olivopontocerebellar atrophy: a long-term follow-up study. Eur Neurol 1999; 41:212-215.
25. Low PA, Gilden JL, Freeman R, Sheng KN, McElligott MA. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group. JAMA 1997; 277:1046-1051. Erratum in: JAMA 1997; 278:388.
26. Zesiewicz TA, Helal M, Hauser RA. Sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men with Parkinson's disease. Mov Disord 2000; 15:305-308.
27. Hussain IF, Brady CM, Swinn MJ, Mathias CJ, Fowler CJ. Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension. J Neurol Neurosurg Psychiatry 2001; 71:371-374.
28. Silber MH, Levine S. Stridor and death in multiple system atrophy. Mov Disord 2000; 15:699-704.
29. Zuscik MJ, Sand S, Ross SA, et al. Overexpression of the alpha 1B-adrenergic receptor causes apoptotic neurodegeneration: multiple system atrophy. Nat Med 2000; 6:1388-1394.